Raffles Medical Group Ltd
RAFLF
$0.8073
$0.05737.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 145.57M | 140.34M | 144.75M | 146.34M | 135.09M |
| Total Other Revenue | -- | -- | 317.70K | 321.20K | -- |
| Total Revenue | 145.57M | 140.34M | 145.07M | 146.66M | 135.09M |
| Cost of Revenue | 78.69M | 75.86M | 79.52M | 80.39M | 74.41M |
| Gross Profit | 66.89M | 64.48M | 65.55M | 66.27M | 60.69M |
| SG&A Expenses | 34.47M | 33.23M | 32.33M | 32.69M | 30.86M |
| Depreciation & Amortization | 8.24M | 7.95M | 8.48M | 8.57M | 7.12M |
| Other Operating Expenses | 8.17M | 7.87M | 8.31M | 8.40M | 7.45M |
| Total Operating Expenses | 129.56M | 124.91M | 128.64M | 130.05M | 119.84M |
| Operating Income | 16.01M | 15.43M | 16.43M | 16.61M | 15.25M |
| Income Before Tax | 16.89M | 16.28M | 16.34M | 16.52M | 16.04M |
| Income Tax Expenses | 4.40M | 4.25M | 4.58M | 4.63M | 4.61M |
| Earnings from Continuing Operations | 12.49M | 12.04M | 11.76M | 11.89M | 11.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -135.80K | -130.90K | 92.70K | 93.70K | -105.70K |
| Net Income | 12.35M | 11.91M | 11.85M | 11.98M | 11.32M |
| EBIT | 16.01M | 15.43M | 16.43M | 16.61M | 15.25M |
| EBITDA | 23.99M | 23.13M | 20.66M | 20.89M | 22.60M |
| EPS Basic | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 1.85B | 1.85B | 1.86B | 1.86B | 1.86B |
| Average Diluted Shares Outstanding | 1.86B | 1.86B | 1.86B | 1.86B | 1.89B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 144.12% | 144.12% | 0.00% | 0.00% | 145.47% |